Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second malignancies in children: the usual suspects?

J Moppett1, A Oakhill, A W Duncan

  • 1Department of Paediatric Oncology, Bristol Royal Hospital for Sick Children, St. Michael's Hill, BS2 8BJ, Bristol, UK.

European Journal of Radiology
|June 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carboplatinum.

Bristol medico-chirurgical journal (1963)·2017
Same author

Epirubicin.

Bristol medico-chirurgical journal (1963)·2017
Same author

Ifosfamide ±VP16 in Childhood' Malignancy: A Phase II (toxicity) Study.

Bristol medico-chirurgical journal (1963)·2017
Same author

Evaluation of coagulopathy before and during induction chemotherapy for acute lymphoblastic leukaemia, including assessment of global clotting tests.

Blood cancer journal·2017
Same author

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Bone marrow transplantation·2015
Same author

Breast milk DHA levels in Sri Lankan mothers vary significantly in three locations that have different access to dietary fish.

The Ceylon medical journal·2013

This review details second malignant neoplasms (SMNs) after childhood cancer treatment, covering incidence, genetic factors, and treatment influences. It highlights key primary and secondary cancers, emphasizing risk identification and radiological diagnosis.

Area of Science:

  • Oncology
  • Genetics
  • Pediatrics

Context:

  • Childhood cancer survivors face increased risks of developing secondary malignant neoplasms (SMNs).
  • Understanding the long-term effects of cancer treatment is crucial for improving patient outcomes.
  • Genetic predisposition plays a significant role in SMN development.

Purpose:

  • To provide an updated review of SMNs following childhood cancer treatment.
  • To discuss the incidence, genetic factors, and treatment-related influences on SMNs.
  • To highlight key primary and secondary malignancies, diagnostic methods, and risk factors.

Summary:

  • This article reviews SMNs in childhood cancer survivors, examining incidence, genetic predispositions, and the impact of primary cancer type and treatment (chemotherapy, radiotherapy).

Related Experiment Videos

  • It focuses on specific associations, including Hodgkin's disease, retinoblastoma, and acute lymphoblastic leukemia, and highlights common SMNs such as CNS tumors, osteosarcoma, and melanoma.
  • Emphasis is placed on identifying high-risk patients and utilizing radiological features for diagnosis and screening, supported by case histories.

    • Impact:

    • Informs clinicians about the risks and patterns of SMNs in childhood cancer survivors.
    • Aids in the development of targeted screening protocols for high-risk individuals.
    • Contributes to personalized survivorship care by considering genetic and treatment factors.